LncRNA MEG3 Reduces the Ratio of M2/M1 Macrophages Through the HuR/CCL5 Axis in Hepatocellular Carcinoma

被引:4
|
作者
Wei, Huamei [1 ]
Wu, Xianjian [2 ]
Huang, Lizheng [3 ]
Long, Chen [3 ]
Lu, Qi [3 ]
Huang, Zheng [3 ]
Huang, Yanyan [3 ]
Li, Wenchuan [2 ]
Pu, Jian [2 ,4 ]
机构
[1] Youjiang Med Univ Nationalities, Affiliated Hosp, Dept Pathol, Baise, Guangxi, Peoples R China
[2] Youjiang Med Univ Nationalities, Affiliated Hosp, Dept Hepatobiliary Surg, Baise, Guangxi, Peoples R China
[3] Youjiang Med Univ Nationalities, Grad Coll, Baise, Guangxi, Peoples R China
[4] Youjiang Med Univ Nationalities, Affiliated Hosp, 18 Zhongshan Two Rd, Baise 533000, Guangxi, Peoples R China
关键词
hepatocellular carcinoma; maternally expressed gene 3; macrophage polarization; human antigen R; C -C motif chemokine 5; LONG NONCODING RNAS; EXPRESSION; CANCER; INVASION; CCL5;
D O I
10.2147/JHC.S449090
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Objective: Tumor-associated macrophages play a crucial role in the development of hepatocellular carcinoma (HCC). Our study aimed to investigate the relationship between long coding RNA (lncRNA) maternally expressed gene 3 (MEG3), RNA-binding protein human antigen R (HuR), and messenger RNA C-C motif chemokine 5 (CCL5) in the modulation of M1 and M2 macrophage polarization in HCC. Methods: To induce M1 or M2 polarization, LPS/IFN gamma- or IL4/IL13 were used to treat bone marrow derived macrophages (BMDMs). The localization of MEG3 in M1 and M2 macrophages was assessed using fluorescence in situ hybridization assay. Expression levels of MEG3, HuR, CCL5, M1, and M2 markers were measured by RT-qPCR or immunofluorescence staining. Flow cytometry was performed to determine the proportion of F4/80+CD206+ and F4/80+CD68+ cells. RNA pulldown assay was performed to detect the binding of lncRNA MEG3 and HuR. The impacts of HuR on CCL5 stability and activity of CCL5 promoter were evaluated using actinomycin D treatment and luciferase reporter assay. Cell migration, invasiveness, and angiogenesis were assessed using transwell migration and invasion assays and a tube formation assay. A mixture of Huh-7 cells and macrophages were injected into nude mice to explore the effect of MEG3 on tumorigenesis. Results: MEG3 promoted M1-like polarization while dampening M2-like polarization of BMDMs. MEG3 bound to HuR in M1 and M2 macrophages. HuR downregulated CCL5 by inhibiting CCL5 transcription in macrophages. In addition, overexpression of MEG3 suppressed cell metastasis, invasion, and angiogenesis by obstructing macrophage M2 polarization. MEG3 inhibited tumorigenesis in HCC via promotion of M1-like polarization and inhibition of M2-like polarization. Rescue experiments showed that depletion of CCL5 in M2 macrophages reversed MEG3-induced suppressive effect on cell migration, invasion, and tube formation. Conclusion: MEG3 suppresses HCC progression by promoting M1-like while inhibiting M2-like macrophage polarization via binding to HuR and thus upregulating CCL5.
引用
收藏
页码:543 / 562
页数:20
相关论文
共 50 条
  • [21] M2 macrophages, but not M1 macrophages, support megakaryopoiesis by upregulating PI3K-AKT pathway activity
    Zhao, Hong-Yan
    Zhang, Yuan-Yuan
    Xing, Tong
    Tang, Shu-Qian
    Wen, Qi
    Lyu, Zhong-Shi
    Lv, Meng
    Wang, Yu
    Xu, Lan-Ping
    Zhang, Xiao-Hui
    Kong, Yuan
    Huang, Xiao-Jun
    SIGNAL TRANSDUCTION AND TARGETED THERAPY, 2021, 6 (01)
  • [22] A high M1/M2 ratio of tumor-associated macrophages is associated with extended survival in ovarian cancer patients
    Zhang, Meiying
    He, Yifeng
    Sun, Xiangjun
    Li, Qing
    Wang, Wenjing
    Zhao, Aimin
    Di, Wen
    JOURNAL OF OVARIAN RESEARCH, 2014, 7
  • [23] Hsa_circ_0010882 facilitates hepatocellular carcinoma progression by modulating M1/M2 macrophage polarization
    Yang, Ming
    Yu, Tao
    Han, Li
    JOURNAL OF VIRAL HEPATITIS, 2024, 31 (04) : 189 - 196
  • [24] A high M1/M2 ratio of tumor-associated macrophages is associated with extended survival in ovarian cancer patients
    Meiying Zhang
    Yifeng He
    Xiangjun Sun
    Qing Li
    Wenjing Wang
    Aimin Zhao
    Wen Di
    Journal of Ovarian Research, 7
  • [25] LncRNA FTX represses the progression of non-alcoholic fatty liver disease to hepatocellular carcinoma via regulating the M1/M2 polarization of Kupffer cells
    Wu, Huajun
    Zhong, Zhiwei
    Wang, Anji
    Yuan, Chunhui
    Ning, Ke
    Hu, Huanhuan
    Wang, Chao
    Yin, Xiangbao
    CANCER CELL INTERNATIONAL, 2020, 20 (01)
  • [26] LncRNA FTX represses the progression of non-alcoholic fatty liver disease to hepatocellular carcinoma via regulating the M1/M2 polarization of Kupffer cells
    Huajun Wu
    Zhiwei Zhong
    Anji Wang
    Chunhui Yuan
    Ke Ning
    Huanhuan Hu
    Chao Wang
    Xiangbao Yin
    Cancer Cell International, 20
  • [27] Role of FTY720 on M1 and M2 macrophages, lymphocytes, and chemokines in 5/6 nephrectomized rats
    Schaier, Matthias
    Vorwalder, Stefanie
    Sommerer, Claudia
    Dikow, Ralf
    Hug, Friederike
    Gross, Marie-Luise
    Waldherr, Ruediger
    Zeier, Martin
    AMERICAN JOURNAL OF PHYSIOLOGY-RENAL PHYSIOLOGY, 2009, 297 (03) : F769 - F780
  • [28] LncRNA MEG3 Inhibits Tumor Progression by Modulating Macrophage Phenotypic Polarization via miR-145-5p/DAB2 Axis in Hepatocellular Carcinoma
    Wei, Qing
    Liu, Guoman
    Huang, Zihua
    Huang, Yanyan
    Huang, Lizheng
    Huang, Zheng
    Wu, Xianjian
    Wei, Huamei
    Pu, Jian
    JOURNAL OF HEPATOCELLULAR CARCINOMA, 2023, 10 : 1019 - 1035
  • [29] An herbal formula Shenlian decoction upregulates M1/M2 macrophage proportion in hepatocellular carcinoma by suppressing complement cascade
    Li, Wenxuan
    You, Liping
    Lin, Jiacheng
    Zhang, Jinghao
    Zhou, Zhijia
    Wang, Tao
    Wu, Yuelan
    Zheng, Chao
    Gao, Yueqiu
    Kong, Xiaoni
    Sun, Xuehua
    BIOMEDICINE & PHARMACOTHERAPY, 2024, 177
  • [30] Inonotsuoxide B regulates M1 to M2 macrophage polarization through sirtuin-1/endoplasmic reticulum stress axis
    Du, Na
    Wu, Kun
    Zhang, Jin
    Wang, Lili
    Pan, Xuesheng
    Zhu, Yueqin
    Wu, Xian
    Liu, Jinghao
    Chen, Yun
    Ye, Ying
    Wang, Yuanyuan
    Wu, Wenyong
    Cheng, Wenming
    Huang, Yan
    INTERNATIONAL IMMUNOPHARMACOLOGY, 2021, 96